Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Environ Sci Technol
2014 Jan 01;483:1964-72. doi: 10.1021/es404568a.
Show Gene links
Show Anatomy links
In silico analysis of the conservation of human toxicity and endocrine disruption targets in aquatic species.
McRobb FM
,
Sahagún V
,
Kufareva I
,
Abagyan R
.
Abstract
Pharmaceuticals and industrial chemicals, both in the environment and in research settings, commonly interact with aquatic vertebrates. Due to their short life-cycles and the traits that can be generalized to other organisms, fish and amphibians are attractive models for the evaluation of toxicity caused by endocrine disrupting chemicals (EDCs) and adverse drug reactions. EDCs, such as pharmaceuticals or plasticizers, alter the normal function of the endocrine system and pose a significant hazard to human health and the environment. The selection of suitable animal models for toxicity testing is often reliant on high sequence identity between the human proteins and their animal orthologs. Herein, we compare in silico the ligand-binding sites of 28 human "side-effect" targets to their corresponding orthologs in Danio rerio, Pimephales promelas, Takifugu rubripes, Xenopus laevis, and Xenopus tropicalis, as well as subpockets involved in protein interactions with specific chemicals. We found that the ligand-binding pockets had much higher conservation than the full proteins, while the peroxisome proliferator-activated receptor γ and corticotropin-releasing factor receptor 1 were notable exceptions. Furthermore, we demonstrated that the conservation of subpockets may vary dramatically. Finally, we identified the aquatic model(s) with the highest binding site similarity, compared to the corresponding human toxicity target.
Figure 1. Variations in sequence conservation across the sequence
of the
AR for D. rerio, P. promelas, T. rubripes, X. laevis, and X.
tropicalis compared to the human AR (binding site residues
highlighted in cyan). All sequences were window averaged across 25
residues. Abbreviations: AF1/2, activation function 1/2; DBD, DNA
binding domain; LBD, ligand binding domain.14
Figure 2. Sequence similarity
(percentage and color) and sequence identity
(number of identical residues/number of aligned residues is shown
in parentheses) for the 28 toxicity target proteins of (a) the full
sequence and (b) the ligand-contact residues conserved for 80% of
the cocrystallized ligands. White spaces indicate that no ortholog
was identified (often due to an incomplete proteome).
Figure 3. (a) Sequence
similarity (percentage and color) and sequence identity
(number of identical residues/number of aligned residues is shown
in parentheses) for the three A2AR subpockets (white spaces
indicate that no ortholog was identified). A2AR crystal
structures (gray ribbons), all cocrystallized ligands (mesh), and
subpocket (solid surface); (b) subpocket 1 (agonist-bound structures),
(c) subpocket 2 (the endogenous agonist-bound structure), and (d)
subpocket 3 (antagonist-bound structures).
Abagyan,
Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins.
1994, Pubmed
Abagyan,
Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins.
1994,
Pubmed
Abagyan,
Do aligned sequences share the same fold?
1997,
Pubmed
Altschul,
Basic local alignment search tool.
1990,
Pubmed
Amores,
Zebrafish hox clusters and vertebrate genome evolution.
1998,
Pubmed
Ankley,
The fathead minnow in aquatic toxicology: past, present and future.
2006,
Pubmed
Aparicio,
Whole-genome shotgun assembly and analysis of the genome of Fugu rubripes.
2002,
Pubmed
Berg,
Xenopus tropicalis as a test system for developmental and reproductive toxicity.
2009,
Pubmed
,
Xenbase
Berman,
The Protein Data Bank.
2000,
Pubmed
Bortolato,
Monoamine oxidase inactivation: from pathophysiology to therapeutics.
2008,
Pubmed
Boswell-Smith,
PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilast.
2007,
Pubmed
Dixit,
Healthy animals and animal models of human disease(s) in safety assessment of human pharmaceuticals, including therapeutic antibodies.
2007,
Pubmed
Ekroos,
Structural basis for ligand promiscuity in cytochrome P450 3A4.
2006,
Pubmed
Flint,
Bisphenol A exposure, effects, and policy: a wildlife perspective.
2012,
Pubmed
Giacomini,
Membrane transporters in drug development.
2010,
Pubmed
Gonnet,
Exhaustive matching of the entire protein sequence database.
1992,
Pubmed
Gunnarsson,
Evolutionary conservation of human drug targets in organisms used for environmental risk assessments.
2008,
Pubmed
Hauger,
International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands.
2003,
Pubmed
Hellsten,
The genome of the Western clawed frog Xenopus tropicalis.
2010,
Pubmed
,
Xenbase
Hirst,
Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.
2003,
Pubmed
Ho,
Estrogen and androgen signaling in the pathogenesis of BPH.
2011,
Pubmed
Hollenstein,
Structure of class B GPCR corticotropin-releasing factor receptor 1.
2013,
Pubmed
Irwin,
Therapeutic potential for GIP receptor agonists and antagonists.
2009,
Pubmed
Janesick,
Minireview: PPARγ as the target of obesogens.
2011,
Pubmed
Kloas,
Endocrine disruption in aquatic vertebrates.
2009,
Pubmed
Kohno,
Novel approaches for the study of vertebrate steroid hormone receptors.
2008,
Pubmed
Kruger,
Global analysis of small molecule binding to related protein targets.
2012,
Pubmed
Kufareva,
Pocketome: an encyclopedia of small-molecule binding sites in 4D.
2012,
Pubmed
Kufareva,
Methods of protein structure comparison.
2012,
Pubmed
Kufareva,
Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment.
2011,
Pubmed
Lounkine,
Large-scale prediction and testing of drug activity on side-effect targets.
2012,
Pubmed
Martin,
Predictive model of rat reproductive toxicity from ToxCast high throughput screening.
2011,
Pubmed
Massarsky,
β-blockers as endocrine disruptors: the potential effects of human β-blockers on aquatic organisms.
2011,
Pubmed
McGrath,
Zebrafish: a predictive model for assessing drug-induced toxicity.
2008,
Pubmed
Milestone,
Evaluating the potential of effluents and wood feedstocks from pulp and paper mills in Brazil, Canada, and New Zealand to affect fish reproduction: chemical profiling and in vitro assessments.
2012,
Pubmed
Milnes,
Activation of steroid and xenobiotic receptor (SXR, NR1I2) and its orthologs in laboratory, toxicologic, and genome model species.
2008,
Pubmed
Mizuo,
Functional changes in dopamine D3 receptors by prenatal and neonatal exposure to an endocrine disruptor bisphenol-A in mice.
2004,
Pubmed
Needleman,
A general method applicable to the search for similarities in the amino acid sequence of two proteins.
1970,
Pubmed
Oba,
Purification and characterization of tributyltin-binding protein of tiger puffer, Takifugu rubripes.
2011,
Pubmed
Owen,
Comparative physiology, pharmacology and toxicology of beta-blockers: mammals versus fish.
2007,
Pubmed
Parrott,
Life-cycle exposure of fathead minnows (Pimephales promelas) to an ethinylestradiol concentration below 1 ng/L reduces egg fertilization success and demasculinizes males.
2005,
Pubmed
Pochapsky,
Conformational plasticity and structure/function relationships in cytochromes P450.
2010,
Pubmed
Postlethwait,
Vertebrate genome evolution and the zebrafish gene map.
1998,
Pubmed
Rothman,
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.
2000,
Pubmed
Searls,
Pharmacophylogenomics: genes, evolution and drug targets.
2003,
Pubmed
Segner,
Zebrafish (Danio rerio) as a model organism for investigating endocrine disruption.
2009,
Pubmed
Setola,
Why mice are neither miniature humans nor small rats: a cautionary tale involving 5-hydroxytryptamine-6 serotonin receptor species variants.
2003,
Pubmed
UniProt Consortium,
Reorganizing the protein space at the Universal Protein Resource (UniProt).
2012,
Pubmed
Vamathevan,
Minipig and beagle animal model genomes aid species selection in pharmaceutical discovery and development.
2013,
Pubmed
Vedani,
VirtualToxLab - a platform for estimating the toxic potential of drugs, chemicals and natural products.
2012,
Pubmed
Vezzosi,
Phosphodiesterases in endocrine physiology and disease.
2011,
Pubmed